Accelerating Your Research Studies

One of the most daunting problems in generating new treatments for disease is that so few patients participate in research, making the clinical development of a new product increasingly costly …and very slow. It is estimated that per-patient clinical trial costs for Phase III clinical trials is now over $40,000!

"Pharma can now partner with patients in a whole new way to expedite discovery and development."

Even before the clinical trial process gets underway, however, there's the challenge of discovering new approaches. In today's genomic world, discoveries can be made based on analyzing large amounts of clinical data from patient health histories, combined with the genomic profiles of these patients.

The quandary, however, is accessing such data rapidly and efficiently.

Your biopharmaceutical company can overcome this challenge by partnering with an existing disease organization, or by connecting with patients who initiate their own online communities. In this way, you have a 'standing army' of motivated individuals who have a vested interest in discovery and development, whose genotypic and phenotypic information (as well as biosamples) can be channeled to benefit all.